Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$6.38 - $18.33 $2.59 Million - $7.45 Million
-406,200 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$12.38 - $19.1 $5.03 Million - $7.76 Million
406,200 New
406,200 $6.76 Million
Q2 2020

Aug 14, 2020

SELL
$27.21 - $41.0 $816,300 - $1.23 Million
-30,000 Closed
0 $0
Q1 2020

May 15, 2020

BUY
$19.54 - $38.85 $586,200 - $1.17 Million
30,000 New
30,000 $898,000

Others Institutions Holding IOVA

About IOVANCE BIOTHERAPEUTICS, INC.


  • Ticker IOVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 157,800,992
  • Market Cap $1.21B
  • Description
  • Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...
More about IOVA
Track This Portfolio

Track Suvretta Capital Management, LLC Portfolio

Follow Suvretta Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Suvretta Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Suvretta Capital Management, LLC with notifications on news.